Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1217)
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
16,300
Price
$18.52
Total Value
$301.92K
Shares Held After
55,286
% of Holdings
22.8%
LeonaBio, Inc. (LONA)
Litton Mark James — Director
Shares
5,156
Price
$5.37
Total Value
$27.69K
Shares Held After
57,926
% of Holdings
8.2%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
69,270
Price
$1.25
Total Value
$86.59K
Shares Held After
3,367,064
% of Holdings
2.1%
LeonaBio, Inc. (LONA)
CHURCH KEVIN — CHIEF SCIENTIFIC OFFICER
Shares
1,359
Price
$5.37
Total Value
$7.30K
Shares Held After
25,178
% of Holdings
5.1%
LeonaBio, Inc. (LONA)
San Martin Javier — CHIEF MEDICAL OFFICER
Shares
1,720
Price
$5.37
Total Value
$9.24K
Shares Held After
15,887
% of Holdings
9.8%
UNITED THERAPEUTICS Corp (UTHR)
KURZWEIL RAY — Director
Shares
4,910
Price
$489.02
Total Value
$2.40M
Shares Held After
12,670
% of Holdings
27.9%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
2,000
Price
$489.42
Total Value
$978.84K
Shares Held After
8,480
% of Holdings
19.1%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
20
Price
$490.17
Total Value
$9.80K
Shares Held After
4,190
% of Holdings
0.5%
FibroBiologics, Inc. (FBLG)
Khoja Hamid — Chief Scientific Officer
Shares
30,000
Price
$0.38
Total Value
$11.40K
Shares Held After
61,250
% of Holdings
49.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,671
Price
$70.94
Total Value
$189.49K
Shares Held After
767,780
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,329
Price
$69.94
Total Value
$512.62K
Shares Held After
770,451
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
447
Price
$86.62
Total Value
$38.72K
Shares Held After
117,134
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,437
Price
$85.78
Total Value
$123.27K
Shares Held After
117,581
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
2,519
Price
$85.04
Total Value
$214.21K
Shares Held After
119,018
% of Holdings
2.1%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
492
Price
$84.00
Total Value
$41.33K
Shares Held After
121,537
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
358
Price
$86.62
Total Value
$31.01K
Shares Held After
73,810
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,150
Price
$85.78
Total Value
$98.65K
Shares Held After
74,168
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
2,017
Price
$85.04
Total Value
$171.52K
Shares Held After
75,318
% of Holdings
2.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
394
Price
$84.00
Total Value
$33.09K
Shares Held After
77,335
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
447
Price
$86.62
Total Value
$38.72K
Shares Held After
232,588
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,437
Price
$85.78
Total Value
$123.27K
Shares Held After
233,035
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
2,519
Price
$85.04
Total Value
$214.21K
Shares Held After
234,472
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
492
Price
$84.00
Total Value
$41.33K
Shares Held After
236,991
% of Holdings
0.2%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
184,208
Price
$14.22
Total Value
$2.62M
Shares Held After
12,229,500
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
2,380
Price
$16.15
Total Value
$38.44K
Shares Held After
1,934,247
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
50,703
Price
$15.49
Total Value
$785.39K
Shares Held After
1,936,627
% of Holdings
2.6%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,367
Price
$2.08
Total Value
$7.01K
Shares Held After
107,465
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$509.20
Total Value
$25.46K
Shares Held After
170
% of Holdings
22.7%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
1,000
Price
$21.89
Total Value
$21.89K
Shares Held After
8,397
% of Holdings
11.9%
Crinetics Pharmaceuticals, Inc. (CRNX)
Schilke Tobin — Chief Financial Officer
Shares
6,713
Price
$39.67
Total Value
$266.30K
Shares Held After
78,121
% of Holdings
7.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
170,000
Price
$3.46
Total Value
$588.20K
Shares Held After
6,259,863
% of Holdings
2.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
3,000
Price
$39.67
Total Value
$119.01K
Shares Held After
13,300
% of Holdings
18.4%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
18,200
Price
$0.41
Total Value
$7.37K
Shares Held After
5,942,275
% of Holdings
0.3%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
1,649
Price
$22.06
Total Value
$36.38K
Shares Held After
37,482
% of Holdings
4.2%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
1,012
Price
$80.82
Total Value
$81.79K
Shares Held After
11,014
% of Holdings
8.4%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
6,794
Price
$80.00
Total Value
$543.49K
Shares Held After
12,026
% of Holdings
36.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
13,526
Price
$79.17
Total Value
$1.07M
Shares Held After
18,820
% of Holdings
41.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Washburn Theodore James Jr. — Principal Accounting Officer
Shares
5,272
Price
$28.88
Total Value
$152.26K
Shares Held After
868
% of Holdings
85.9%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
802
Price
$80.76
Total Value
$64.77K
Shares Held After
80,554
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
12,687
Price
$79.88
Total Value
$1.01M
Shares Held After
81,356
% of Holdings
13.5%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
71,600
Price
$79.10
Total Value
$5.66M
Shares Held After
94,043
% of Holdings
43.2%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
1,005
Price
$80.80
Total Value
$81.20K
Shares Held After
3,811
% of Holdings
20.9%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
14,608
Price
$79.88
Total Value
$1.17M
Shares Held After
4,816
% of Holdings
75.2%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
39,265
Price
$79.11
Total Value
$3.11M
Shares Held After
19,424
% of Holdings
66.9%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
10,000
Price
$17.38
Total Value
$173.80K
Shares Held After
42,391
% of Holdings
19.1%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
36
Price
$81.01
Total Value
$2.92K
Shares Held After
4,347
% of Holdings
0.8%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
2,088
Price
$80.41
Total Value
$167.89K
Shares Held After
4,383
% of Holdings
32.3%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
4,096
Price
$79.36
Total Value
$325.06K
Shares Held After
41,317
% of Holdings
9.0%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
832
Price
$80.33
Total Value
$66.83K
Shares Held After
36,330
% of Holdings
2.2%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
755
Price
$80.84
Total Value
$61.03K
Shares Held After
22,541
% of Holdings
3.2%
Showing 851–900 of 1217 transactions (page 18 of 25)